Work

Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain

Year: 2025

Type: article

Abstract: disease in a preclinical in vivo study.

Source: Blood Neoplasia

DOI: 10.1016/j.bneo.2025.100109

Authors: Elias Lagonik, Elyse C. Page, John B. Bruning, Laura N. Eadie, Susan L. Heatley, Matthew Greenwood, Chun Y. Fong, Andrew S. Moore, David T. Yeung, Timothy P. Hughes, Deborah L. White

Institutions: South Australian Health and Medical Research Institute, The University of Adelaide, The University of Sydney, Royal North Shore Hospital, Australasian Leukaemia and Lymphoma Group, The University of Melbourne, Austin Health, The University of Queensland, ANZCHOG, Children's Health Queensland Hospital and Health Service, Royal Adelaide Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: South Australian Health and Medical Research Institute, Australian Cancer Research Foundation, University of Adelaide, Department of Health and Aged Care, Australian Government, Government of Western Australia, National Health and Medical Research Council, Cancer Council South Australia

Awards: G1259034822, A curative approach for chronic myeloid leukaemia

OpenAlex ID: W4409817551

FWCI: 4.113

Cites: 48

Cited by: 5

Related to: 10